Bijuva FDA Approval History
FDA Approved: Yes (First approved October 28, 2018)
Brand name: Bijuva
Generic name: estradiol and progesterone
Dosage form: Capsules
Previous Name: TX-001HR
Company: TherapeuticsMD, Inc.
Treatment for: Perimenopausal Symptoms, Postmenopausal Symptoms
Bijuva (estradiol and progesterone) is a bio-identical hormone combination for the treatment of moderate-to-severe vasomotor symptoms (hot flashes) due to menopause.
Development timeline for Bijuva
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.